CERo Therapeutics Holdings (CERO)
NASDAQ:CERO
US Market
Holding CERO?
Track your performance easily

CERo Therapeutics Holdings (CERO) Financial Statements

97 Followers

CERo Therapeutics Holdings Financial Overview

CERo Therapeutics Holdings's market cap is currently ―. The company's EPS TTM is $-0.405; its P/E ratio is -0.20; CERo Therapeutics Holdings is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.45M$ -305.75K$ -308.28K$ -1.39M$ -434.31K
EBITDA$ -2.26M$ -305.75K$ -308.28K$ -1.39M$ -434.31K
Net Income Common Stockholders$ -2.45M$ -282.76K$ -334.03K$ -1.44M$ -481.71K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 96.87K$ 119.01K$ 105.23K$ 178.09K
Total Assets$ 7.37M$ 8.56M$ 8.47M$ 14.11M$ 14.43M
Total Debt$ 2.15M$ 0.00$ 1.40M$ 1.18M$ 650.00K
Net Debt$ 2.15M$ -96.87K$ 1.28M$ 1.07M$ 471.91K
Total Liabilities$ 9.85M$ 14.32M$ 13.95M$ 13.56M$ 12.44M
Stockholders Equity$ -2.48M$ -14.20M$ -13.77M$ -13.29M$ -11.58M
Cash Flow-
Free Cash Flow$ -2.26M$ -186.61K$ -256.12K$ -883.10K$ -197.78K
Operating Cash Flow$ -2.26M$ -186.61K$ -256.12K$ -883.10K$ -197.78K
Investing Cash Flow-$ -13.82M$ 5.69M$ 285.24K$ -100.00K
Financing Cash Flow-$ -27.68M$ -5.42M$ 525.00K-
Currency in USD

CERo Therapeutics Holdings Earnings and Revenue History

CERo Therapeutics Holdings Debt to Assets

CERo Therapeutics Holdings Cash Flow

CERo Therapeutics Holdings Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis